Skip to main content
SpringerLink
Log in

Sickle Cell Disease (SCD): Usefulness of Transcranial Doppler (TCD/TCCS) Monitoring

  • Chapter
  • First Online:
Neurosonology in Critical Care

  • 1686 Accesses

Abstract

Stroke is a major and serious event among patients affected by sickle cell disease (SCD), especially at a younger age, where it is a leading cause of death and disability. Due to its potentially reversible pathophysiological mechanisms, prevention by early recognition as well as screening tools is essential for those affected by this disease. In this chapter, we discuss different approaches and strategies for the early detection among patients at risk of stroke, with special focus on the development of transcranial Doppler ultrasound (TCD/TCCS) as a reliable, easy-to-use, cost-effective tool and its dramatic effects in lowering stroke-related mortality and burden of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Antonello D, et al. Transcranial Doppler ultrasound: physical principles and principal applications in Neurocritical Care Unit. J Cardiovasc Echogr. 2016;26(2):29–41.

    Google Scholar 

  2. Saqqur M, et al. Role of transcranial Doppler in neurocritical care. Crit Care Med. 2007;35(5 Suppl):S216–23.

    Article  PubMed  Google Scholar 

  3. Bulas D, et al. Transcranial Doppler: applications in neonates and children. Ultrasound Clin. 2009;4:533–51.

    Article  Google Scholar 

  4. Naqvi J, et al. Transcranial Doppler ultrasound: a review of the physical principles and major applications in critical care. Intl J Vasc Med. 2013;1:1–13.

    Google Scholar 

  5. Winkler P, et al. Major Pitfalls in Doppler investigations, with particular reference to the cerebral vascular system. Pediatr Radiol. 1990;20:219–28.

    Article  CAS  PubMed  Google Scholar 

  6. Fujioka K, et al. Anatomy and free hand examination techniques. In: Newell D, editor. Transcranial Doppler. New York: Raven Press; 1992. p. 9–31.

    Google Scholar 

  7. Switzer J, et al. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006;5:501–12.

    Article  PubMed  Google Scholar 

  8. Gladwin MT, et al. Cardiovascular complications and risk of death in sickle-cell disease. Lancet. 2016;387:2565–74.

    Article  PubMed  Google Scholar 

  9. Rodrigues D, et al. Genetic determinants and stroke in children with sickle cell disease. J Pediatr (Bra). 2016;92(6):602–8.

    Article  Google Scholar 

  10. Ohene-Frempong K, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–29.

    CAS  PubMed  Google Scholar 

  11. Conran N, et al. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin. 2009;33:1–16.

    Article  CAS  PubMed  Google Scholar 

  12. Balkaran B, et al. Stroke in a Cohort of patients with homozygous sickle cell disease. J Pediatr. 1992;120:360–6.

    Article  CAS  PubMed  Google Scholar 

  13. Powars D, et al. The natural history of stroke in sickle cell disease. Am J Med. 1978;65:461–71.

    Article  CAS  PubMed  Google Scholar 

  14. Sabarense A, et al. Characterization of mortality in children with sickle cell disease. J Pediatr (Bra). 2015;91:242–7.

    Article  Google Scholar 

  15. Golomb M, et al. International Pediatric Stroke Study Group. Male predominance in childhood ischemic stroke. Stroke. 2009;40:52–7.

    Article  PubMed  Google Scholar 

  16. DeBaun M, et al. Central nervous system complications and management in sickle cell disease. Blood. 2016;127(7):829–83.

    Article  CAS  PubMed  Google Scholar 

  17. Platt O, et al. Preventing stroke in sickle cell anemia. N Engl J Med. 2005;353(26):2743–5.

    Article  CAS  PubMed  Google Scholar 

  18. Russell M, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood. 1984;63(1):162–9.

    Article  CAS  PubMed  Google Scholar 

  19. Adams R. Big Strokes in Small Persons. Arch Neurol. 2007;64(11):1567–74.

    Article  PubMed  Google Scholar 

  20. Pavlakis S, et al. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol. 1988;23(2):125–30.

    Article  CAS  PubMed  Google Scholar 

  21. Adams R, et al. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke. 1992;23(8):1073–7.

    Article  CAS  PubMed  Google Scholar 

  22. Goldstein L, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32(1):280–99.

    Article  CAS  PubMed  Google Scholar 

  23. Adams R, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998;19(1):110–29.

    Article  CAS  PubMed  Google Scholar 

  24. Fullerton H, et al. Declining rates in Californian children with sickle cell disease. Blood. 2004;104(2):336–9.

    Article  CAS  PubMed  Google Scholar 

  25. Adams R, et al. Transcranial doppler re-screening of subjects who participated in STOP and STOP II. Am J Hematol. 2016;91:1191–4.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kwiatkowski J, et al. Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era. Am J Hematol. 2019;94:1335–43.

    Article  PubMed  Google Scholar 

  27. Ware R, et al. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016;387:661–70.

    Article  CAS  PubMed  Google Scholar 

  28. Opoka R, et al. Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort. Haematologica. 2020;105(6):e272–5.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wali Y, et al. Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region. Hematology. 2020;25(1):55–62.

    Article  CAS  PubMed  Google Scholar 

  30. Greenwood S, et al. The significance of inadequate transcranial Doppler studies in children with sickle cell disease. PLoS One. 2017;12(7):e0181681.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Schlenz A, et al. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. atr Blood Cancer. 2020;67:e28172.

    Google Scholar 

  32. Bulas D, et al. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol. 2000;30(11):733–8.

    Article  CAS  PubMed  Google Scholar 

  33. Jones A, et al. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005;35(1):66–72.

    Article  PubMed  Google Scholar 

  34. Alshehri E, et al. The role of MRA in pediatric sickle cell disease with normal transcranial Doppler imaging velocities. J Stroke Cerebrovasc Dis. 2020;29(7):104864.

    Article  PubMed  Google Scholar 

  35. Estcourt L, et al. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2020;4:CD012389.

    PubMed  Google Scholar 

  36. Cardoso A. An experimental erythrocyte rigidity index (Ri) and its correlations with Transcranial Doppler velocities (TAMMV), Gosling Pulsatility Index PI, hematocrit, hemoglobin concentration and red cell distribution width (RDW). PLoS One. 2020;15(2):e0229105.

    Article  CAS  Google Scholar 

  37. Weisman J, et al. Transcranial Doppler screening adherence among children with sickle cell anemia seen in the emergency department. J Pediatr. 2019;10:1–5.

    Google Scholar 

  38. Inusa B, et al. An educational study promoting the delivery of transcranial Doppler ultrasound screening in paediatric sickle cell disease: a European Multi-Centre Perspective. J Clin Med. 2020;9:44.

    Article  Google Scholar 

  39. Seibert J, et al. Transcranial Doppler, MRA and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8 year study. Pediatr Radiol. 1998;28(7):546.

    Google Scholar 

  40. Sheehan V, et al. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke. Pediatr Blood Cancer. 2013;60(9):1499–502.

    Article  PubMed  Google Scholar 

  41. Silva G, et al. Brain magnetic resonance imaging abnormalities in adult patients with sickle cell disease: correlation with transcranial Doppler findings. Stroke. 2009;40(7):2408–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Neurology Department, Hospital Universitario Valle del Lili, Cali, Colombia

    Juan Fernando Gómez Castro

Authors
  1. Juan Fernando Gómez Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan Fernando Gómez Castro .

Editor information

Editors and Affiliations

  1. Department of Critical Care, University of Buenos Aires, Buenos Aires, Argentina

    Camilo N. Rodríguez

  2. Stroke Unit & Neurosonology Lab, University of Padua School of Medicine, Padova, Italy

    Claudio Baracchini

  3. Department of Critical Care and Anesthesiology, Fundación Valle del Lili, Cali, Colombia

    Jorge H. Mejia-Mantilla

  4. Department of Clinical Neurosciences Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK

    Marek Czosnyka

  5. Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Jose I Suarez

  6. President of Hungarian Neurological Society, Department of Neurology, Clinical Center Debrecen University, Debrecen, Hungary

    László Csiba

  7. Intensive Care Unit, Clinics Hospital, Universidad de la Republica School of Medicine, Montevideo, Uruguay

    Corina Puppo

  8. Center for Neurological Vascular Diagnostics, Munich, Germany

    Eva Bartels

Algorithm

Algorithm

figure a

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Castro, J.F.G. (2022). Sickle Cell Disease (SCD): Usefulness of Transcranial Doppler (TCD/TCCS) Monitoring. In: Rodríguez, C.N., et al. Neurosonology in Critical Care . Springer, Cham. https://doi.org/10.1007/978-3-030-81419-9_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81419-9_42

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81418-2

  • Online ISBN: 978-3-030-81419-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation